General Information of the Compound
Compound ID
CP0050692
Compound Name
(1S,2R,3S)-1-Benzo[1,3]dioxol-5-yl-3-(2-carboxymethoxy-4-methoxy-phenyl)-5-propoxy-indan-2-carboxylic acid
    Show/Hide
Synonyms
(+/-)-SB 209670
SB-209670
SKF-66861
    Show/Hide
Structure
Formula
C29H28O9
Molecular Weight
520.534
Canonical SMILES
CCCOc1ccc2[C@@H]([C@H]([C@@H](c2c1)c1ccc(OC)cc1OCC(O)=O)C(O)=O)c1ccc2OCOc2c1
    Show/Hide
InChI
InChI=1S/C29H28O9/c1-3-10-35-18-6-7-19-21(12-18)27(20-8-5-17(34-2)13-23(20)36-14-25(30)31)28(29(32)33)26(19)16-4-9-22-24(11-16)38-15-37-22/h4-9,11-13,26-28H,3,10,14-15H2,1-2H3,(H,30,31)(H,32,33)/t26-,27+,28+/m0/s1
    Show/Hide
InChIKey
UUAVCCWBNUITBB-UPRLRBBYSA-N
CAS
157659-79-5
Physicochemical Property
logP
4.6543
Rotatable Bonds
10
Heavy Atom Count
38
Polar Areas
120.75
Hydrogen Bond Donor Count
2
Hydrogen Bond Acceptor Count
7
Complexity
38

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 108002
SID: 14860653
ChEMBL ID
CHEMBL8823
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01783, Endothelin receptor type B
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 14.7 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 14.7 nM
2 Ki = 18 nM
Protein ID: PT01372, Endothelin-1 receptor
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000011 CHO Cricetulus griseus (Chinese hamster)  1
1
Ki = 0.43 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 Ki = 0.2 nM
2 Ki = 0.43 nM
Clinical Information about the Compound
Drug 1 ( SB-209670 )
Drug Name SB-209670
Company SmithKline Beecham plc
Indication
Arrhythmia
Discontinued in Phase 2
Target(s)
Endothelin A receptor (EDNRA)
Modulator
Endothelin B receptor (EDNRB)
Modulator